BSE Circulars (21849)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces non-competitive bidding facility for two Government of India dated securities (6.68% GS 2040 and 7.43% GS 2076) to be … | |||||||||||||||
BSE announces non-competitive bidding facility for two Government of India dated securities (6.68% GS 2040 and 7.43% GS 2076) to be auctioned on April 30, 2026, with settlement on May 4, 2026.
| |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Windlas Biotech Ltd, open from April 30 to May 7, 2026, at Rs. 1000 … | |||||||||||||||
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Windlas Biotech Ltd, open from April 30 to May 7, 2026, at Rs. 1000 per share for up to 4,70,000 equity shares.
| |||||||||||||||
BSE notifies trading members of part redemption and interest payment record dates for non-convertible debentures/bonds of 10 companies, with … | |||||||||||||||
BSE notifies trading members of part redemption and interest payment record dates for non-convertible debentures/bonds of 10 companies, with trading in these instruments to continue at reduced face values from respective ex-dates.
| |||||||||||||||
BSE notifies trading members of partial redemption of Pass Through Certificates (PTCs) of MAGNETRON AUG 2025, with reduced face values of … | |||||||||||||||
BSE notifies trading members of partial redemption of Pass Through Certificates (PTCs) of MAGNETRON AUG 2025, with reduced face values of Rs. 4747.31 and Rs. 8006.21 per PTC effective April 30, 2026.
| |||||||||||||||
BSE introduces a standardised penalty structure for Investment Advisers effective May 1, 2026, covering non-compliances under SEBI … | |||||||||||||||
BSE introduces a standardised penalty structure for Investment Advisers effective May 1, 2026, covering non-compliances under SEBI (Investment Advisers) Regulations, 2013.
| |||||||||||||||
BSE introduces a standardised penalty structure for Research Analysts to address non-compliances under SEBI (Research Analysts) Regulations, … | |||||||||||||||
BSE introduces a standardised penalty structure for Research Analysts to address non-compliances under SEBI (Research Analysts) Regulations, 2013, effective May 1, 2026.
| |||||||||||||||
BSE/ICCL notice detailing the settlement schedule for the Offer to Buy acquisition window under the buyback program for Windlas Biotech … | |||||||||||||||
BSE/ICCL notice detailing the settlement schedule for the Offer to Buy acquisition window under the buyback program for Windlas Biotech Limited.
| |||||||||||||||
BSE notice applying minimum 35% margin requirement in Equity and Equity Derivatives segments for securities with high promoter encumbrance … | |||||||||||||||
BSE notice applying minimum 35% margin requirement in Equity and Equity Derivatives segments for securities with high promoter encumbrance effective May 5, 2026, with some securities exiting the framework from April 30, 2026.
| |||||||||||||||
BSE places additional securities under the Additional Surveillance Measure framework for companies undergoing Insolvency Resolution Process … | |||||||||||||||
BSE places additional securities under the Additional Surveillance Measure framework for companies undergoing Insolvency Resolution Process (IRP) under IBC, effective April 30, 2026, while certain securities are removed from the framework.
| |||||||||||||||
BSE notifies suspension of trading in Sovereign Gold Bond 2019 Series (ISIN: IN0020180033, Scrip Code: 800287) with effect from April 30, … | |||||||||||||||
BSE notifies suspension of trading in Sovereign Gold Bond 2019 Series (ISIN: IN0020180033, Scrip Code: 800287) with effect from April 30, 2026, as the security reaches its redemption date.
| |||||||||||||||